Name: Tyrosine-protein kinase BMX Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

Tyrosine-protein kinase BMX Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	Ibrutinib	IC50	0.8 ^[1]
	4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline	IC50	303.0 ^[1], 324.0 ^[2], 1100.0 ^[3]
	Bosutinib	IC50	1.0 ^[1], 7.9 ^[2]
	Canertinib	IC50	62.0 ^[1], 586.0 ^[2]
	Nvp-tae 684	IC50	1578.0 ^[1], 600000.0 ^[2]
Rows per page: 1–5 of 100

References

This online resource may be cited as follows

MLA	"Quest Database™ Tyrosine-protein kinase BMX Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 18 Dec. 2025, https://www.aatbio.com/data-sets/tyrosine-protein-kinase-bmx-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2025, December 18). Quest Database™ Tyrosine-protein kinase BMX Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/tyrosine-protein-kinase-bmx-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan